A detailed history of Elk River Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Elk River Wealth Management, LLC holds 5,611 shares of ABBV stock, worth $963,577. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,611
Previous 5,641 0.53%
Holding current value
$963,577
Previous $967,000 14.58%
% of portfolio
0.2%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $4,915 - $5,979
-30 Reduced 0.53%
5,611 $1.11 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $243,405 - $277,338
-1,523 Reduced 21.26%
5,641 $1.03 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $2,252 - $2,803
-17 Reduced 0.24%
7,164 $965,000
Q1 2023

Apr 12, 2023

SELL
$144.61 - $166.54 $85,609 - $98,591
-592 Reduced 7.62%
7,181 $1.14 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $13,001 - $15,591
-94 Reduced 1.19%
7,773 $0
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $21,876 - $25,090
-163 Reduced 2.03%
7,867 $1.06 Million
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $35,766 - $44,376
-271 Reduced 3.26%
8,030 $1.3 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $79,605 - $100,724
741 Added 9.8%
8,301 $1.12 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $18,939 - $21,498
-178 Reduced 2.3%
7,560 $815,000
Q2 2021

Jul 22, 2021

SELL
$105.21 - $117.21 $3,892 - $4,336
-37 Reduced 0.48%
7,738 $872,000
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $23,017 - $25,339
225 Added 2.98%
7,775 $841,000
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $607,699 - $820,458
7,550 New
7,550 $809,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Elk River Wealth Management, LLC Portfolio

Follow Elk River Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elk River Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elk River Wealth Management, LLC with notifications on news.